Association Between Alcohol Drinking Patterns and Multiple Metabolic Syndrome Components in Non‐Obese and Obese Individuals
Neuropsychopharmacology Reports · 2026-06 · 46 (2)
DOI: 10.1002/npr2.70105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropsychopharmacology Reports, online erschienen am 15.03.2026. Verfasst von Ayako Kikuchi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba-shi, Japan. Hauptthemen laut MEDLINE: Metabolic Syndrome, Alcohol Drinking, Obesity. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Tokio Marine dR Co. Ltd.
Abstract (Originalsprache)
Aim
This cross‐sectional study aimed to investigate the relationship between drinking patterns (combination of the frequency and amount of alcohol consumption) and the possession of multiple metabolic syndrome (MetS) components in non‐obese and obese individuals.
Methods
Data derived from medical examinations, specific health checkup questionnaires, and health insurance claims of 36 006 individuals aged 40–64 years from five health insurance associations affiliated with Japanese companies were analyzed. Modified Poisson regression analysis was conducted with multiple MetS components as the objective variable, drinking patterns as the explanatory variable, and sex, age, weight gain ≥ 10 kg since the age of 20 years, and lifestyle habits except for drinking patterns as adjustment variables.
Results
Drinking patterns associated with a high risk of possessing multiple MetS components were “everyday drinking” ≥ 20 g/day and “sometimes drinking” ≥ 40 g/day in non‐obese individuals and “everyday drinking” ≥ 60 g/day in obese individuals. Across these risky drinking patterns, the prevalence ratios for the possession of multiple MetS components were higher in non‐obese individuals than in obese individuals. Conversely, drinking patterns associated with a lower risk of possessing multiple MetS components were “everyday drinking < 20 g/day” in non‐obese individuals and “sometimes drinking < 20 g/day” and “everyday drinking < 20 g/day” in obese individuals.
Conclusion
Non‐obese individuals, even when drinking less frequently and in smaller amounts, showed a higher risk of possessing multiple MetS components than obese individuals, underscoring the importance of supporting reduced alcohol consumption among non‐obese individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba-shi, Japan.
- Research and Development Center for Lifestyle Innovation, University of Tsukuba, Tsukuba-shi, Japan.
- Department of Family Medicine, General Practice and Community Health, Institute of Medicine, University of Tsukuba, Tsukuba-shi, Japan.
- Institute of Health and Sport Sciences, University of Tsukuba, Tsukuba-shi, Japan.
- Self-Employed Consultant, Asaka-shi, Japan.
ORCID-Profile: Ayako Kikuchi, Hisashi Yoshimoto, Takafumi Monma, Fumi Takeda
Förderung
- Tokio Marine dR Co. Ltd
Zitieren
APA
Kikuchi, A., Yoshimoto, H., Monma, T., Ozawa, S., Tsuchida, M., & Takeda, F. (2026). Association Between Alcohol Drinking Patterns and Multiple Metabolic Syndrome Components in Non‐Obese and Obese Individuals. Neuropsychopharmacology Reports, 46(2). https://doi.org/10.1002/npr2.70105
Vancouver
Kikuchi A, Yoshimoto H, Monma T, Ozawa S, Tsuchida M, Takeda F. Association Between Alcohol Drinking Patterns and Multiple Metabolic Syndrome Components in Non‐Obese and Obese Individuals. Neuropsychopharmacology Reports. 2026;46(2). doi:10.1002/npr2.70105
BibTeX
@article{Kikuchi2026,
author = {Kikuchi, Ayako and Yoshimoto, Hisashi and Monma, Takafumi and Ozawa, Sakiko and Tsuchida, Momoko and Takeda, Fumi},
title = {Association Between Alcohol Drinking Patterns and Multiple Metabolic Syndrome Components in Non‐Obese and Obese Individuals},
journal = {Neuropsychopharmacology Reports},
year = {2026},
volume = {46},
number = {2},
doi = {10.1002/npr2.70105}
}
EUVIMED